
The Rheox System – Galvanize
The RheOx ® system for the treatment of the symptoms of chronic bronchitis consists of a proprietary electrosurgical generator and a single-use catheter. The minimally-invasive …
Bronchial Rheoplasty for Treatment of Chronic Bronchitis. Twelve …
Bronchial rheoplasty is a procedure that uses nonthermal pulsed electrical fields with the intention of ablating the abnormal mucus-producing cells of the airway epithelium, thereby allowing …
RheOx Bronchial Rheoplasty (GalaRheSolve) - Emphysema COPD …
What is Bronchial Rheoplasty? This is a device therapy being studied for patients with COPD and chronic sputum production. In the study, a small tube called a bronchoscope is placed in the …
RheOx™ for Chronic Bronchitis - Respiratory Research Center
Right now, doctors at our research center are conducting a new research study of Bronchial Rheoplasty using RheOx™, an investigational device designed to reduce cough and mucus …
COPD: Positive Data for RheOx Bronchial Rheoplasty System
2020年9月4日 · RheOx is a bronchoscopic system designed to reduce mucus-producing cells in patients with chronic bronchitis. The technology includes an electrosurgical generator and a …
A Study to Evaluate RheOx Bronchial Rheoplasty System to Treat …
2022年9月29日 · Observational study — observes people and measures outcomes without affecting results. Interventional study (clinical trial) — studies new tests, treatments, drugs, …
Galvanize Therapeutics Completes Enrollment in Pivotal Trial of RheOx …
2023年6月19日 · The minimally invasive RheOx System delivers non-thermal pulsed electric field (PEF) energy to destroy abnormal, mucus-producing cells on the surface of the lung airways.
Temple Health testing RheOx, a new breakthrough treatment for …
2020年8月17日 · Antibiotics and steroids can give short-term relief, but there's no cure for chronic bronchitis, and long-term treatments have been limited. Temple is one of the U.S. sites testing …
FDA OKs Pivotal Trial Testing RheOx System in Chronic Bronchitis
2021年2月23日 · The upcoming trial, called RheSolve (NCT04677465), will evaluate the safety and effectiveness of the RheOx System in up to 270 adults, ages 35 and older, with COPD …
GALA THERAPEUTICS: Receives FDA Breakthrough Device ... - FDA …
2019年9月17日 · RheOx is a bronchoscopic system designed to reduce mucus-producing cells in patients with Chronic Bronchitis. The revolutionary technology includes an electrosurgical …
- 某些结果已被删除